Figure 13-3 Schematic representation of the onset of a neuromuscular block after administration of a depolarizing neuromuscular blocking agent at the arrow. Neuromuscular function is monitored with repetitive train-of-four stimuli (four stimuli of 0.5-msec duration administered over a period of 2 seconds).